A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK®) lowering cardiovascular disease risk by Manfrin A, Trimarco V, Manzi MV, Rozza F, Izzo R

Get full text

Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9 by Adorni MP, Ferri N, Marchianò S, Trimarco V, Rozza F, Izzo R, Bernini F, Zimetti F

Get full text

Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessment by Seekircher, L, Tschiderer, L, Lind, L, Safarova, MS, Kavousi, M, Ikram, MA, Lonn, E, Yusuf, S, Grobbee, DE, Kastelein, JJP, Visseren, FLJ, Walters, M, Dawson, J, Higgins, P, Agewall, S, Catapano, A, de Groot, E, Espeland, MA, Klingenschmid, G, Magliano, D, Olsen, MH, Preiss, D, Sander, D, Skilton, M, Zozulińska-Ziółkiewicz, DA, Grooteman, MPC, Blankestijn, PJ, Kitagawa, K, Okazaki, S, Manzi, MV, Mancusi, C, Izzo, R, Desvarieux, M, Rundek, T, Gerstein, HC, Bots, ML, Sweeting, MJ, Lorenz, MW, Willeit, P